150 results on '"Hertel, Andreas"'
Search Results
2. Selbstorganisation – ein bewährtes Phänomen
3. Eine Frage der Kultur
4. Kritische Perspektive
5. Rheumatologie/Entzündungsdiagnostik
6. Selbstorganisation mit Holakratie
7. Resümee
8. Einleitung
9. Fazit
10. Inklusive Haltung macht den Unterschied : Die Rolle von Bedürfnissen und Beziehungen in der Potenzialentfaltung
11. Potenzialentfaltung als Balanceakt der Bedürfnisse von Organisation und Mensch : Fallstudie: Die Alpha AG versucht Menschlichkeit mit Höchstleistungen zu verbinden
12. Beziehungsgestaltung in unsicheren Zeiten
13. Soziale Innovationen in Organisationen gestalten : Einen förderlichen Rahmen für gelingende Kooperation und Potenzialentfaltung schaffen
14. Potenzialentfaltung durch bedingungslose Zugehörigkeit : Fallstudie: Die Beta GmbH investiert in Beziehung und Vertrauen, um die Mitarbeitenden in ihrer Potenzialentfaltung zu unterstützen
15. Von der alten zur neuen Ordnung
16. Potenziale
17. Einführung
18. Soziale Innovationen in der Führung
19. Molekulare Onkologie
20. Lungentumoren
21. Entzündungsdiagnostik
22. Gastroenterologische Tumoren
23. Dermatologische Tumoren
24. Six versus eight doses of rituximab in patients with aggressive B cell lymphoma receiving six cycles of CHOP: results from the “Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas” (PETAL) trial
25. Soziale Innovationen in der Führung : Potenziale freisetzen durch Partizipation und Vertrauen
26. Relationship between dopamine D 2 receptor occupancy, clinical response, and drug and monoamine metabolites levels in plasma and cerebrospinal fluid. A pilot study in patients suffering from first-episode schizophrenia treated with quetiapine
27. Positron emission tomography with [18F]FDG in the diagnosis of Creutzfeldt-Jakob disease (CJD)
28. Interim PET Evaluation in Diffuse Large B-Cell Lymphoma Using Published Recommendations: Comparison of the Deauville 5-Point Scale and the ΔSUVmax Method
29. Baseline and interim PET‐based outcome prediction in peripheral T‐cell lymphoma: A subgroup analysis of the PETAL trial
30. The N141I Mutation in PSEN2: Implications for the Quintessential Case of Alzheimer Disease
31. Comparison of metabolic and receptor imaging in recurrent medullary thyroid carcinoma with histopathological findings
32. Interim PET evaluation in diffuse large B-cell lymphoma employing published recommendations: Comparison of the Deauville 5-point scale and the ΔSUVmax method.
33. Interim PET evaluation in diffuse large B-cell lymphoma employing published recommendations: Comparison of the Deauville 5-point scale and the ΔSUVmax method.
34. Hertel, Andreas Høymann
35. Positron Emission Tomography (PET) Guided Therapy of Aggressive Lymphomas - Interim PET-Based Outcome Prediction and Treatment Changes in Patients with T Cell Lymphomas Participating in the PETAL Trial
36. Positron Emission Tomography (PET) Guided Therapy of Aggressive Lymphomas - Interim PET-Based Outcome Prediction and Treatment Changes in Patients with B Cell Lymphomas Participating in the PETAL Trial
37. Follow-Up in Carriers of the ‘MELAS’ Mutation without Strokes
38. Positron Emission Tomography (PET) Guided Therapy of Aggressive Lymphomas – a Randomized Controlled Trial Comparing Different Treatment Approaches Based on Interim PET Results (PETAL Trial)
39. Retraction notice to “Relationship between dopamine D2 receptor occupancy, clinical response, and drug and monoamine metabolites levels in plasma and cerebrospinal fluid. A pilot study in patients suffering from first-episode schizophrenia treated with quetiapine” [J Psychiat Res 44 (2010) 754–759]
40. Quetiapine and Norquetiapine in Plasma and Cerebrospinal Fluid of Schizophrenic Patients Treated With Quetiapine
41. RETRACTED: Relationship between dopamine D2 receptor occupancy, clinical response, and drug and monoamine metabolites levels in plasma and cerebrospinal fluid. A pilot study in patients suffering from first-episode schizophrenia treated with quetiapine
42. PET with 2-[F-18]-Fluoro-2-Deoxy-D-Glucose (FDG) in Patients with Cancer of Unknown Primary (CUP): Influence on Patients' Diagnostic and Therapeutic Management
43. Positron emission tomography with [ 18 F]FDG in the diagnosis of Creutzfeldt-Jakob disease (CJD)
44. Positron Emission Tomography (PET) for Staging and Evaluation of Response to Treatment in Patients with Hodgkin's Disease
45. Multimodal imaging of residual function and compensatory resource allocation in cortical atrophy: a case study of parietal lobe function in a patient with Huntington's disease
46. Follow-Up in Carriers of the ‘MELAS’ Mutation without Strokes
47. Can response to partial sleep deprivation in depressed patients be predicted by regional changes of cerebral blood flow?
48. Influence of Human Anti-Murine Antibodies on in vitro Assays in Ovarian Cancer Patients
49. A Novel Technetium-99M Labeled Monoclonal Antibody (174H.64) For Staging Head and Neck Cancer by Immuno-Spect
50. Is PET superior to MRI in the pretherapeutic evaluation of head and neck squamous cell carcinoma?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.